What's Next: Upcoming Readouts in 2026 TRIUMPH-1 (pivotal obesity) on May 21, 2026 (up to -30.3% at 104 weeks), and TRIUMPH-2 and TRIUMPH-3 together on July 23, 2026 (-20.8% and -22.6% at 12 mg)
Its commercial name was Byetta
Pros: Free medication, medical monitoring, compensation for time, high-quality product Cons: You might receive placebo, strict eligibility criteria, time commitment (regular visits) How to find trials: ClinicalTrials.gov, Lilly Trial Guide 2
What Patients Should Not Do After GLP-1 Weight Loss Patients should not treat GLP-1 success as permission to stop paying attention to metabolic health
Request Your Consultation If you are ready to take the next step in your health journey, schedule a consultation at Vitalogy Wellness and Med-Spa in Homewood Alabama
There is no need for a formal transfer of records, though knowing your current dose and any side effects you have experienced helps the new provider make informed decisions